Strategies and Applications of Antigen-Binding Fragment (Fab) Production in Escherichia coli
With the advancement of genetic engineering, monoclonal antibodies (mAbs) have made far-reaching progress in the treatment of various human diseases. However, due to the high cost of production, the increasing demands for antibody-based therapies have not been fully met. Currently, mAb-derived alter...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Georg Thieme Verlag KG
2021-06-01
|
| Edice: | Pharmaceutical Fronts |
| Témata: | |
| On-line přístup: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1735145 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
